Quantification of rat brain SPECT with 123I-ioflupane: evaluation of different reconstruction methods and image degradation compensations using Monte Carlo simulation

SPECT studies with (123)I-ioflupane facilitate the diagnosis of Parkinson's disease (PD). The effect on quantification of image degradations has been extensively evaluated in human studies but their impact on studies of experimental PD models is still unclear. The aim of this work was to assess the effect of compensating for the degrading phenomena on the quantification of small animal SPECT studies using (123)I-ioflupane. This assessment enabled us to evaluate the feasibility of quantitatively detecting small pathological changes using different reconstruction methods and levels of compensation for the image degrading phenomena. Monte Carlo simulated studies of a rat phantom were reconstructed and quantified. Compensations for point spread function (PSF), scattering, attenuation and partial volume effect were progressively included in the quantification protocol. A linear relationship was found between calculated and simulated specific uptake ratio (SUR) in all cases. In order to significantly distinguish disease stages, noise-reduction during the reconstruction process was the most relevant factor, followed by PSF compensation. The smallest detectable SUR interval was determined by biological variability rather than by image degradations or coregistration errors. The quantification methods that gave the best results allowed us to distinguish PD stages with SUR values that are as close as 0.5 using groups of six rats to represent each stage.

[1]  J. Benlloch,et al.  Development of a variable-radius pinhole SPECT system with a portable gamma camera. , 2011, Revista espanola de medicina nuclear.

[2]  Simon R Cherry,et al.  Small-animal preclinical nuclear medicine instrumentation and methodology. , 2008, Seminars in nuclear medicine.

[3]  Nils Schramm,et al.  Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  Irène Buvat,et al.  Review and current status of SPECT scatter correction , 2011, Physics in medicine and biology.

[5]  Falcon Falcon,et al.  Métodos iterativos de reconstrucción tomográfica en SPECT , 1999 .

[6]  I Buvat,et al.  Monte Carlo simulations in SPET and PET. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[7]  Koen Van Laere,et al.  EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  M. Desco,et al.  A SPECT Scanner for Rodent Imaging Based on Small-Area Gamma Cameras , 2010, IEEE Transactions on Nuclear Science.

[9]  P. Acton,et al.  Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation* , 2008, Journal of Nuclear Medicine.

[10]  C. Antke,et al.  Effects of l-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat , 2013, Nuclear medicine communications.

[11]  M. Farrer,et al.  Missing pieces in the Parkinson's disease puzzle , 2010, Nature Medicine.

[12]  A. Evans,et al.  Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  M S Rosenthal,et al.  Quantitative SPECT imaging: a review and recommendations by the Focus Committee of the Society of Nuclear Medicine Computer and Instrumentation Council. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  Alberto Del Guerra,et al.  State-of-the-art of PET, SPECT and CT for small animal imaging , 2007 .

[15]  Alberto Del Guerra,et al.  SMALL ANIMAL SCANNERS , 2004 .

[16]  Pablo Aguiar,et al.  Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  Alain Pitiot,et al.  A multimodal, multidimensional atlas of the C57BL/6J mouse brain , 2004, Journal of anatomy.

[18]  Habib Zaidi,et al.  Scatter modelling and compensation in emission tomography , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  B. Hasegawa,et al.  Assessment of the sources of error affecting the quantitative accuracy of SPECT imaging in small animals , 2008, Physics in medicine and biology.

[20]  Javier Pavía,et al.  Iterative reconstruction with correction of the spatially variant fan-beam collimator response in neurotransmission SPET imaging , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  Jerry L Prince,et al.  Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  M. S. Kaplan,et al.  Preliminary Experience With The Photon History Generator Module Of A Public-domain Simulation System For Emission Tomography , 1993, 1993 IEEE Conference Record Nuclear Science Symposium and Medical Imaging Conference.

[23]  Klaus Tatsch,et al.  Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update , 2013, The Journal of Nuclear Medicine.

[24]  Catafau Am,et al.  Brain SPECT of dopaminergic neurotransmission: a new tool with proved clinical impact. , 2001 .

[25]  Gerda Andringa,et al.  Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease , 2005, NeuroImage.

[26]  Cristina Lavini,et al.  Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible. , 2003, Nuclear medicine and biology.

[27]  D. Ros,et al.  Monte Carlo simulation of small animal SPECT studies with 123I-labeled radiotracers using high and low energy photons in a modified version of SimSET , 2011, 2011 IEEE Nuclear Science Symposium Conference Record.

[28]  Habib Zaidi,et al.  Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use? , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  A. Raasmaja,et al.  High correlation between in vivo [123I]β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats , 2013, EJNMMI Research.

[30]  J. Booij,et al.  [123I]FP‐CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP‐lesioned monkeys , 1997, Synapse.

[31]  I. Buvat,et al.  A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology , 2012, Physics in medicine and biology.

[32]  Javier Pavía,et al.  Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  Habib Zaidi,et al.  Which attenuation coefficient to use in combined attenuation and scatter corrections for quantitative brain SPET? , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  J. Humm,et al.  Accuracy and precision of radioactivity quantification in nuclear medicine images. , 2012, Seminars in nuclear medicine.

[35]  H Zaidi,et al.  Relevance of accurate Monte Carlo modeling in nuclear medical imaging. , 1999, Medical physics.